C-reactive protein, immunothrombosis and venous thromboembolism
C-reactive protein (CRP) is a member of the highly conserved pentraxin superfamily of proteins and is often used in clinical practice as a marker of infection and inflammation. There is now increasing evidence that CRP is not only a marker of inflammation, but also that destabilized isoforms of CRP...
Main Authors: | Caroline Dix, Johannes Zeller, Hannah Stevens, Steffen U. Eisenhardt, Karen S. Cheung Tung Shing, Tracy L. Nero, Craig J. Morton, Michael W. Parker, Karlheinz Peter, James D. McFadyen |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2022-09-01
|
Series: | Frontiers in Immunology |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fimmu.2022.1002652/full |
Similar Items
-
Decoding the role of platelets in tumour metastasis: enigmatic accomplices and intricate targets for anticancer treatments
by: Jessie Zhao, et al.
Published: (2023-12-01) -
Predicting the Risk of Recurrent Venous Thromboembolism: Current Challenges and Future Opportunities
by: Hannah Stevens, et al.
Published: (2020-05-01) -
Submassive Pulmonary Embolism: Current Perspectives and Future Directions
by: Phillip C. Nguyen, et al.
Published: (2021-07-01) -
P2Y12 Antagonists in Cardiovascular Disease—Finding the Best Balance Between Preventing Ischemic Events and Causing Bleeding
by: Himawan Fernando, et al.
Published: (2022-05-01) -
Beyond Choice: Reading Sigmund Freud at the End of <i>Roe</i>
by: Karen McFadyen
Published: (2023-10-01)